BDX Q2 2019 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q2 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.2B-0.6% YoY

Gross Profit

$2.0B47.1% margin

Operating Income

$136M3.2% margin

Net Income

$20M0.5% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

$780M

Free Cash Flow

$585M

Stock-Based Comp.

$59M

Balance Sheet

Total Assets

$52.6B

Total Liabilities

$31.3B

Stockholders' Equity

$21.3B

Cash & Equivalents

$686M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.2B	$4.2B	-0.6%
Gross Profit	$2.0B	$1.6B	+22.9%
Operating Income	$136M	$186M	-26.9%
Net Income	$20M	-$12M	+266.7%

Revenue Segments

Medical

$2.2B52%

Life Sciences

$1.1B25%

Interventional

$963M23%

Geographic Segments

UNITED STATES

$2.3B56%

Non-US

$1.9B44%